Discover 1,107 paid clinical trials in Alabama. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Alabama provides a diverse range of research opportunities for healthy volunteers and individuals with specific health conditions. Leading research centers in Birmingham, Montgomery, and Mobile are seeking participants, offering access to innovative treatments and cutting-edge medical care.
Filter
1
Filter results
Results: 1,107
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Location: Boston MA, New York NY, Charlottesville VA, Durham NC,
Sponsor: Edwards Lifesciences
Sex: All
Age: 0+
Code: NCT02744677
Recruiting
Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury
for
Acute Kidney Injury
Location: Langhorne PA, Bethlehem PA, Norfolk VA, Orlando FL,
Sponsor: SeaStar Medical
Sex: All
Age: 18+
Code: NCT05758077
Recruiting
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
for
Carcinoma, Non-Small-Cell Lung
Location: Westbrook ME, Worcester MA, Hartford CT, New York NY,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06890598
Phase3, Recruiting
A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1
for
Neurofibromatosis Type 1
Location: New York NY, Philadelphia PA, Baltimore MD,
Sponsor: Healx Limited
Sex: All
Age: 12+
Code: NCT06541847
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
The HOME Study (Healthy Options Made Easy): Telehealth Nutrition Sessions for People Living With Brain Injury
for
Brain Injuries
Location: Tuscaloosa AL
Sponsor: University of Alabama, Tuscaloosa
Sex: All
Age: 18+
Code: NCT05965947
Recruiting
Monitoring HER2+ Breast Cancer Neoadjuvant Treatment With Advanced PET/MRI